me down hahaha my average is lower than the directors that all increased their holdings at 7.5 cents. 10 million in funding and 10 million market cap on a drug that’s revolutionary, on a drug where peers are at a 70-100 milllion market cap at pre clinical success and a drug that has a ton of news flow in the coming quarter. Wherever this goes will still end up multi bagging
But keep Downramping a penny worth it’s cash pile your a genius
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-172
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
